Vimta Labs Limited

Web: vimta.com NSE: VIMTALABS BSE: 524394 SECTOR: Healthcare - Healthcare Services

565 19(-3%)

Volume

2L as on 23, Jun

Open

994

High

1,012

Low

991

584

VWAP

571

52 Week High

903

52 Week Low

376

Viand Research Rating

Quality Score

54/100

Growth Score

65/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,525

No. of Shares

4.47

P/E

41.39

P/B

6.21

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

15.01

ROCE

Profit Growth

Listing Date

15-Dec-05

Promoter Holding

35.67%

FII Holding

4.42%

DII Holding

0.37%

Price Chart

Price Performance

1 Week6%

1 Month26%

3 Months43%

6 Months28%

1 Year28%

YTD28%

Moving Average

5 Day SMA565

10 Day SMA550

20 Day SMA522

30 Day SMA500

50 Day SMA491

61 Day SMA477

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	586	573	580	585
Resistance 2	580	572	576	580
Resistance 1	575	571	574	574
Pivot Point	570	570	570	569
Support 1	565	569	566	564
Support 2	559	568	563	558
Support 3	554	567	559	553

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(-0.21) 35.67%	(0.01) 35.85%	(-0.11) 35.89%	(-0.71) 35.99%	(0.01) 36.67%	(-0.11) 36.70%	(-0.11) 36.76%	(0.01) 36.89%	(0.01) 36.89%	(-0.11) 36.92%	(0.01) 36.98%	(-0.21) 37.00%	(0.01) 37.23%	(0.01) 37.25%	(-0.21) 37.26%	(0.01) 37.46%	(0.01) 37.46%	(0.01) 37.46%	(0.01) 37.46%	(0.01) 37.46%
FIIs	(-0.51) 4.42%	(0.31) 4.89%	(0.31) 4.59%	(0.81) 4.33%	(-0.21) 3.49%	(-0.21) 3.66%	(0.51) 3.81%	(-1.91) 3.31%	(0.01) 5.16%	(2.31) 5.13%	(0.11) 2.88%	(0.01) 2.74%	(0.51) 2.72%	(0.01) 2.25%	(1.81) 2.28%	(0.11) 0.49%	(0.01) 0.35%	(0.21) 0.36%	(0.21) 0.19%	(0.01) 0.00%
DIIs	(0.21) 0.37%	(0.01) 0.13%	(-0.81) 0.11%	(-0.61) 0.87%	(0.01) 1.42%	(0.31) 1.43%	(1.21) 1.15%	(-1.51) 0.00%	(0.01) 1.49%	(0.01) 1.50%	(0.01) 1.49%	(-0.61) 1.50%	(0.01) 2.14%	(0.01) 2.14%	(0.11) 2.13%	(0.01) 2.04%	(0.01) 2.01%	(0.11) 1.96%	(0.51) 1.91%	(0.01) 1.40%
Public	59.55%	59.12%	59.40%	58.80%	58.42%	58.20%	58.28%	59.80%	56.45%	56.45%	58.65%	58.75%	57.92%	58.37%	58.35%	60.02%	60.18%	60.22%	60.44%	61.14%
No. of Shareholders	50,190	51,623	54,467	55,933	30,829	26,183	21,156	20,114	19,054	18,550	19,957	18,429	17,439	17,162	18,916	18,283	18,106	18,332	19,194	19,947

Quarterly Results

	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	90	85	75	80	75	66	83	82	77	80	79	74	67	76	61
Sales Growth % (YoY)	20.6%	29.3%	-10.3%	-2.6%	-3.6%	-17.9%	5.5%	10.4%	14.9%	5.8%	29%	23.8%	14.8%	27.2%	87.2%
Sales Growth % (QoQ)	5.9%	13.3%	-6.2%	6.7%	13.6%	-20.5%	1.2%	6.5%	-3.8%	1.3%	6.8%	10.4%	-11.8%	24.6%	-
Expenses	57	55	49	55	51	48	59	58	56	54	55	51	47	56	45
Operating Profit	33	30	26	24	24	17	25	24	21	25	24	23	21	20	17
OPM %	37	35	35	31	32	27	30	30	28	32	30	31	31	26	27
Other Income	5	-1	-1	0	-1	0	1	1	1	1	1	0	1	-1	0
Interest	1	0	0	1	1	1	0	0	1	1	1	1	0	0	0
Depreciation	10	8	8	8	8	9	8	8	8	8	7	7	6	6	6
Profit before tax	28	20	17	16	14	8	16	17	14	18	17	16	15	13	11
Tax %	23	24	26	24	25	25	25	23	27	26	28	27	25	25	26
Net Profit	22	15	12	12	10	6	12	13	10	13	12	12	12	10	8
Net Profit Growth % (QoQ)	46.7%	25%	-	20%	66.7%	-50%	-7.7%	30%	-23.1%	8.3%	-	-	20%	25%	-
Net Profit Growth % (YoY)	120%	150%	-	-7.7%	-	-53.8%	-	8.3%	-16.7%	30%	50%	-	-	-	-
TTM Net Profit	61	49	40	40	41	41	48	48	47	49	46	42	30	18	0
EPS in Rs	4.84	3.44	2.77	2.79	2.29	1.43	2.75	2.86	2.32	2.99	2.72	2.68	2.64	4.41	3.65

Profit and Loss

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Sales	318	318	278	211	181
Sales Growth %	0%	14.3%	32.1%	16.6%	-
Expenses	231	223	198	158	151
Operating Profit	87	95	80	53	30
OPM %	27	30	29	25	17
Other Income	4	3	0	1	3
Interest	2	3	2	2	4
Depreciation	34	31	23	23	21
Profit before tax	54	65	56	29	8
Tax %	25	26	26	25	17
Net Profit	41	48	41	21	7
Net Profit Growth %	-14.6%	17.1%	95.2%	200%	-
EPS in Rs	9.26	10.87	9.35	4.84	1.55
Dividend Payout %	11	9	11	21	0

Cash Flows

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash from Operating Activity	61	88	59	37	24
Cash from Investing Activity	-76	-57	-38	-32	-21
Cash from Financing Activity	-2	-11	-17	-5	-1
Net Cash Flow	-17	20	5	1	3

Balance Sheet

	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Equity Capital	4	4	4	4	4	4
Reserves	338	315	277	230	190	168
Borrowings	12	19	15	19	30	33
Other Liabilities	86	61	65	54	50	40
Total Liabilities	440	400	362	307	274	246
Fixed Assets	183	171	175	169	135	138
CWIP	75	59	12	0	17	2
Investments	0	0	0	0	0	0
Other Assets	183	170	175	138	122	106
Total Assets	440	400	362	307	274	246

Delivery

#	Date	436 45% 634	Value (Cr)	Q/T 32	Del 30	Del 18
1	22-Jul	584	211	35	9	19
2	21-Jul	600	376	50	9	34
3	20-Jul	530	52	25	20	10
4	17-Jul	559	5	26	48	3
5	16-Jul	564	5	23	47	2
6	15-Jul	573	35	29	26	9
7	14-Jul	553	7	19	46	3
8	13-Jul	556	6	29	47	3
9	10-Jul	566	7	14	36	2
10	9-Jul	559	14	21	33	5
11	8-Jul	538	8	21	45	3
12	7-Jul	553	8	19	44	4
13	6-Jul	566	10	25	51	5
14	3-Jul	585	9	25	32	3
15	2-Jul	587	5	27	47	2
16	1-Jul	583	9	19	41	4
17	30-Jun	588	8	24	26	2
18	29-Jun	584	14	21	39	5
19	25-Jun	598	33	29	37	12
20	24-Jun	592	36	30	39	14
21	23-Jun	571	10	24	42	4
22	22-Jun	570	10	21	40	4
23	19-Jun	571	14	30	32	4
24	18-Jun	567	90	34	20	18
25	17-Jun	544	11	29	45	5
26	16-Jun	537	7	22	42	3
27	15-Jun	546	14	26	44	6
28	12-Jun	555	44	29	30	13
29	11-Jun	521	10	22	27	3
30	10-Jun	519	18	24	29	5
31	9-Jun	528	9	22	40	4
32	8-Jun	527	29	24	32	9
33	5-Jun	544	66	33	26	17
34	4-Jun	513	21	21	32	7
35	3-Jun	513	49	32	25	12
36	2-Jun	470	4	22	43	2
37	1-Jun	462	6	22	36	2
38	29-May	470	14	32	37	5
39	27-May	457	3	21	49	2
40	26-May	462	5	25	37	2
41	25-May	459	5	27	49	2
42	22-May	452	4	23	40	1
43	21-May	450	5	31	39	2
44	20-May	450	4	21	34	2
45	19-May	453	5	20	33	2
46	18-May	445	7	21	38	3
47	15-May	450	5	23	48	3
48	14-May	461	7	24	37	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	2,525c	76c	2.92
22-Jul	2,601c	89c	3.29
21-Jul	2,689c	200c	8.04
17-Jul	2,489c	18c	0.71
16-Jul	2,507c	70c	2.73
15-Jul	2,577c	124c	5.05
14-Jul	2,453c	40c	1.62
13-Jul	2,494c	38c	1.49
10-Jul	2,531c	30c	1.20
09-Jul	2,502c	111c	4.63
08-Jul	2,391c	81c	3.28
07-Jul	2,472c	57c	2.23
06-Jul	2,528c	87c	3.32
02-Jul	2,615c	25c	0.94
30-Jun	2,640c	58c	2.15
29-Jun	2,698c	42c	1.57
26-Jun	2,656c	19c	0.69
25-Jun	2,675c	57c	2.18
24-Jun	2,618c	58c	2.27
23-Jun	2,560c	18c	0.72
22-Jun	2,541c	9c	0.37
19-Jun	2,551c	125c	5.16
17-Jun	2,426c	23c	0.96
16-Jun	2,403c	50c	2.03
15-Jun	2,452c	13c	0.54
12-Jun	2,466c	130c	5.57
11-Jun	2,336c	43c	1.80
10-Jun	2,379c	0	0

Stock Checklist

Price is below from 52 week high low average: 28%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Jul26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	-	0

Vimta Labs Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements